Prevention of interstitial pressure change at unilateral nephrectomy by prostaglandin synthesis inhibition

Hahne, Bengt; Persson, A. Erik G.
January 1984
Kidney International;Jan1984, Vol. 25 Issue 1, p42
Academic Journal
The mechanisms underlying the adaptive process in the remaining kidney after unilateral nephrectomy are not well known. In the present study adaptive changes in interstitial pressure conditions following uninephrectomy were investigated in male Sprague-Dawley rats. Direct subcapsular hydrostatic pressure recordings were made via microcatheters, renal lymph was collected for lymph flow rate estimations and determinations of lymph protein content and the urine flow rate and urinary excretion of sodium and potassium were measured, before and after contralateral nephrectomy. There was a significant rise in subcapsular hydrostatic pressure by about 50%, and in the lymph flow rate, by more than 100%, within 1 hr after nephrectomy. The protein concentration in collected renal lymph was significantly decreased (from 2.30 ± 0.25 to 1.45 ± 0.26 g/dl), compared with control collections in sham-operated animals (from 2.22 ± 0.23 to 1.78 ± 0.19 g/dl). These findings indicate an increased hydrostatic and decreased interstitial pressure in response to contralateral nephrectomy. Urine flow rate and electrolyte excretion were significantly elevated (urine flow rate by 92%, sodium excretion from 0.210 ± 0.035 to 0,352 ± 0.067 μmoles/min and potassium excretion from 0.306 ± 0.074 to 1.617 ± 0.228 μmoles/min). Inhibition of prostaglandin synthesis prior to nephrectomy abolished the lymph flow increase and oncotic pressure decrease and also the diuretic and natriuretic responses. The adaptively increased potassium excretion was, however, only blocked by diclofenac sodium and not by indomethacin. These results demonstrate the important role of the renal interstitium and the prostaglandin system in the renal adaptation to nephron loss.


Related Articles

  • Serotonin and the renal blood supply: Role of prostaglandins and the 5HT-2 receptor. Blackshear, Joseph L.; Orlandi, Cesare; Hollenberg, Norman K. // Kidney International;Sep1986, Vol. 30 Issue 3, p304 

    Serotonin (5HT) has been reported to increase, to decrease, or not to change renal blood flow. We postulated that prostaglandin release in response to 5HT acted as a confusing variable and tested the hypothesis by comparing infusions of serotonin and angiotensin into one renal artery of 14...

  • Functional inhibition of erectile process in rats by indomethacin. Senbel, Amira // World Journal of Urology;Aug2011, Vol. 29 Issue 4, p523 

    Objectives: Despite the important role played by prostaglandins in the control of erection, the potential contribution of non-steroidal anti-inflammatory drugs in erectile dysfunction in experimental animals has not been investigated. We examined the effect of the selective COX-2 inhibitor,...

  • Functional consequences at the single-nephron level of the lack of adenosine A1 receptors and tubuloglomerular feedback in mice. Vallon, V.; Richter, K.; Huang, D. Y.; Rieg, T.; Schnermann, J. // Pflugers Archiv European Journal of Physiology;May2004, Vol. 448 Issue 2, p214 

    Mice deficient for adenosine A1 receptors (A1AR) lack tubuloglomerular feedback (TGF). In vivo micropuncture experiments were performed under anesthesia in A1AR-deficient and wild-type littermate mice to study the effects of chronic absence of A1AR on fluid and Na+ reabsorption along the...

  • Nephrogenic diabetes insipidus: treat with caution. Boussemart, Thierry; Nsota, Jacqueline; Martin–Coignard, Dominique; Champion, Gérard // Pediatric Nephrology;Sep2009, Vol. 24 Issue 9, p1761 

    Current therapy for congenital nephrogenic diabetes insipidus consists of appropriate water intake coupled with decreased urine output obtained by means of a low-sodium diet and a combination of thiazide diuretics with renal prostaglandins inhibitors or amiloride. We report a case of congenital...

  • Indomethacin Inhibits Duodenal Mucosal Bicarbonate Secretion and Endogenous Prostaglandin E Output in Human Subjects. Selling, John A.; Hogan, Daniel L.; Aly, Andreas; Koss, Michael A.; Isenberg, Jon I. // Annals of Internal Medicine;Mar87, Vol. 106 Issue 3, p368 

    Examines the effect of indomethacin on duodenal mucosal bicarbonate secretion and prostaglandin output in healthy persons. Measurement of bicarbonate concentration in the test segment effluent by a validated back-titration method; Dosage of indomethacin given that resulted in the decrease in...

  • Indomethacin-Induced Rises in Blood Pressure. Gerber, John G. // Annals of Internal Medicine;Oct83, Vol. 99 Issue 4, p555 

    Editorial. Focuses on the influence of indomethacin in increased blood pressure. Physiological effect of renal prostaglandins; Description of prostaglandins; Conditions that are associated with the administration of indomethacin; Influence of prostaglandins in the control of cardiac output.

  • Indomethacin increases plasma lithium. Frolich, J.C.; Leftwich, R.; Ragheb, M.; Oates, J.A.; Reimann, I.; Buchanan, D. // British Medical Journal;4/28/1979, Vol. 1 Issue 6171, p1115 

    Investigates the effects of indomethacin on plasma lithium concentrations and renal lithium clearance. Reduction of renal lithium clearance; Measurement of PGE[sub 2] metabolite with mass spectrometry; Effect of a prostaglandin-dependent mechanism on the renal clearance.

  • Furosemide-Induced Bronchodilation in the Rat Bronchus: Evidence of a Role for Prostaglandins. Almirall, J.J.; Dolman, C.S.; Eidelman, D.H. // Lung;1997, Vol. 175 Issue 3, p155 

    Pretreatment with inhaled fuorsemide has been shown to protect against bronchoconstrictive stimuli that indirectly activate airway smooth muscle. However, it is controversial as to whether furosemide acts directly on airway smooth muscle. To investigate this we studied the effect of...

  • Prostaglandin EP receptor subtypes and gastric cytoprotection. Takeuchi, Koji; Hase, Shoko; Takeeda, Masanori; Nakashima, Masato; Yokota, Aya // Inflammopharmacology;2002, Vol. 10 Issue 4-6, p303 

    This article reviews recent studies dealing with the relationship between the cytoprotective action of PGE[sub 2] and the EP receptor subtypes in the gastric mucosa. Gastric cytoprotection afforded by PGE[sub 2] was mimicked by EP1 agonists and attenuated by the EP1 antagonist. Likewise, the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics